Vulnerable Plaque: Are Targeted Therapies Within Reach?
Rupture of unstable non-obstructive plaque is the underlying cause of most acute coronary syndromes. However, imaging tests to identify high-risk plaque features such as thin-cap fibroatheroma (TCFA) or spotty calcification are not practical for everyday use and have had mixed success for predicting future events.
Read more
March 2023
AI awards help build evidence base for technologies – health secretary
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
Read more
March 2023
THE BIOTECHNOLOGY BOOM IN OXFORD: A LOOK AT 15 EXCITING STARTUPS
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…